Scott Lippman named vice chancellor, transitioning from UCSD Moores director role

KU Cancer Center and Health System receive $20M in new federal investments

The University of Kansas Cancer Center and the University of Kansas Health System received $20 million in new federal investments.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

To help accelerate research into new treatments for acute myeloid leukemia and myelodysplastic syndrome, Thermo Fisher Scientific Inc. is partnering with NCI on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

July 26, 2024

Vol.50 No.30

Clinical Roundup

Screenings overlook hereditary genetic risk for some cancers

Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer syndrome and Lynch syndrome, which increase the risk of developing certain cancers. This issue is particularly pronounced among underrepresented minorities.

July 19, 2024

Vol.50 No.29

Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

What can NCI accomplish in data science?

July 12, 2024

Vol.50 No.28

By Paul Goldberg

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

Kate Choi grew up hearing conversations about skin cancer. Her grandparents had it, as did her cousins.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

Clinical

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.

June 28, 2024

Vol.50 No.26

By Matthew Bin Han Ong

Scott Lippman named vice chancellor, transitioning from UCSD Moores director role

YOU MAY BE INTERESTED IN

KU Cancer Center and Health System receive $20M in new federal investments

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

Screenings overlook hereditary genetic risk for some cancers

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Renew today!

Subscriber content

Login

Scott Lippman named vice chancellor, transitioning from UCSD Moores director role

YOU MAY BE INTERESTED IN

KU Cancer Center and Health System receive $20M in new federal investments

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

Screenings overlook hereditary genetic risk for some cancers

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forwardNCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Login

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists